This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Prospective microbiological study on patients with...
Clinical trial

Prospective microbiological study on patients with non-constipation IBS treated with rifaximin 550 mg tablets.

Read time: 1 mins
Last updated:3rd Feb 2011
To determine the effect of Rifaximin 550 mg treatment on the faecal microflora of patients with non-constipation Irritable Bowel Syndrome (non-C IBS).
Category Value
Study start date 2011-02-03

View full details